Results 141 to 150 of about 41,612 (247)

The Cell-Matrix Interface: a Possible Target for Treating Retinal Vascular Related Pathologies

Journal of Ophthalmic & Vision Research, 2012
Retinal vasculature related pathologies account for a large proportion of global blindness. Choroidal neovascularization accompanying age-related macular degeneration is the largest cause of blindness in people over the age of 65 years, proliferative ...
Gopalan Gnanaguru, William J Brunken
doaj  

Long‐term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registry

Acta Ophthalmologica, Volume 104, Issue 4, Page e382-e396, June 2026.
Abstract Purpose To evaluate long‐term outcomes of anti‐VEGF therapy for nAMD using the Polish Retinal Therapeutic Program Monitoring Registry. Methods The cohort consisted of 63 840 eyes with nAMD qualified for treatment from 2016 to 2022, with follow‐up through 31 October 2023. Long‐term follow‐up (>5 years) was conducted for 7631 eyes.
Sławomir Teper, Daniel Ledwoń, Adam Sendecki, Patrycja Romaniszyn‐Kania, Aleksandra Tuszy, Julia Nycz, Andrzej W. Mitas, Małgorzata Figurska, Edward Wylęgała, Marek Rękas   +9 more
wiley   +1 more source

[Pathogenesis of retinal neovascularization].

Klinika oczna, 1992
Presented are the causes and actual opinions on the pathogenesis of retinal neovascularization. The ischaemic hypothesis of neovascularization is particularly discussed; it is commonly accepted to day as the most probable hypothesis.
openaire   +1 more source

Effects of intravitreal injection of netrin-1 in retinal neovascularization of streptozotocin-induced diabetic rats

, 2015
Yao Yu,1,2,* Jing Zou,3,* Yun Han,4 Luowa Quyang,4 Hui He,4 Peihong Hu,2 Yi Shao,2 Ping Tu11Nanchang Key Laboratory of Diabetes, Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Jiangxi, People’s Republic of China ...
Zou J, Shao Y, Tu P, He H, Han Y, Quyang L, Yu Y, Hu P   +7 more
core  

Study on the Role of Short Peptide LCKLSL Targeting ANXA2 in Retinal Neovascularization. [PDF]

In Vivo
Bai J, Wang Y, Zhao S.
europepmc   +1 more source

Charge-flip nanoparticles loaded with TAK1 inhibitors inhibit retinal neovascularization. [PDF]

J Nanobiotechnology
Teng X, Yuan Z, Li M, Sun L, Xiong X, Sha X, Liu L, Yu G, Tu L, Chan L, Zhong J.   +10 more
europepmc   +1 more source

IL-6 trans-signaling: an overlooked driver of retinal neovascularization? [PDF]

Angiogenesis
Jung M, Ness JN, Schwämmle ME, Rapp J, Boneva S, Groß O, Mitschke J, Schlunck G, Agostini H, Hannibal L, Bucher F.   +10 more
europepmc   +1 more source

Transcriptional Comparison of Human and Murine Retinal Neovascularization. [PDF]

Invest Ophthalmol Vis Sci, 2023
Pauleikhoff L, Boneva S, Boeck M, Schlecht A, Schlunck G, Agostini H, Lange C, Wolf J.   +7 more
europepmc   +1 more source

Integrin β3 Promotes Retinal Neovascularization via Endoplasmic Reticulum Stress-Mediated Endothelial Cell Senescence. [PDF]

Invest Ophthalmol Vis Sci
Qian Y, Song Y, Ma J.
europepmc   +1 more source

AAV2-antiVEGFscFv gene therapy for retinal neovascularization. [PDF]

Mol Ther Methods Clin Dev, 2023
Han N, Xu X, Liu Y, Luo G.
europepmc   +1 more source